REQUEST A DEMO
Total
USD $0.00
Search more companies

Volvax Baltic OU (Estonia)

Main Activities: Automobile Dealers | New Car Dealers
Secondary Activities: Automotive Parts and Accessories Stores
Full name: Volvax Baltic OU Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Volvax Baltic OU is an Estonian biotechnology company specializing in vaccine development, research, and production. Its business segments include biopharmaceutical research, clinical trials, vaccine manufacturing, and regulatory compliance. Geographic scope includes Estonia and selected European and international markets. Key assets include research laboratories, manufacturing facilities, intellectual property, and scientific expertise. Strategically, the company is positioned as an innovative biotech firm focusing on vaccine development, clinical advancement, and market entry in health sectors.

Headquarters
Parnu mnt 232/5 Kristiine linnaosa
Tallinn; Harju county; Postal Code: 11314

Contact Details: Purchase the Volvax Baltic OU report to view the information.

Basic Information
Total Employees:
Purchase the Volvax Baltic OU report to view the information.
Registered Capital:
Purchase the Volvax Baltic OU report to view the information.
Financial Auditors:
Purchase the Volvax Baltic OU report to view the information.
Incorporation Date:
February 06, 2014
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Volvax Baltic OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
8.46%
Total operating revenue
8.46%
Operating profit (EBIT)
80.56%
EBITDA
78.59%
Net Profit (Loss) for the Period
286.71%
Total Assets
61.27%
Total Equity
239.56%
Operating Profit Margin (ROS)
0.01%
Net Profit Margin
0.01%
Return on Equity (ROE)
8.6%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?